Results 161 to 170 of about 38,480 (291)

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source

Clinical experience with apixaban in atrial fibrillation: implications of AVERROES

, 2011
Raffaele De Caterina
openalex   +2 more sources

Letter by Replogle and Moore Regarding Article, “Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation” [PDF]

, 2014
William H. Replogle, Shannon Pittman Moore   +1 more
openalex   +1 more source

Response to Letter Regarding Article, “Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation” [PDF]

, 2014
Lars Wallentin, Renato D. Lópes, Michael Hanna, Laine Thomas, Anne S. Hellkamp, Sunil Nepal, Elaine M. Hylek, Sana M. Al‐Khatib, John H. Alexander, Marco Alings, John Amerena, Jack Ansell, Philip E. Aylward, Jozef Bartúnek, Patrick Commerford, Raffaele De Caterina, Çetin Erol, Veli-Pekka Harjola, Claes Held, John D. Horowitz, Kurt Huber, Steen Husted, Mátyás Keltai, Fernando Laņas, Lisheng Liu, John J.V. McMurray, Byung‐Hee Oh, Mårten Rosenqvist, Witold Rużyłło, Philippe Gabríel Steg, Dragoş Vinereanu, Denis Xavier, Christopher B. Granger   +32 more
openalex   +1 more source

Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation [PDF]

, 2014
Paul Dorian, Thitima Kongnakorn, Hemant Phatak, Dale Rublee, Andreas Kuznik, Tereza Lanitis, Liu Lz, U Iloeje, Luis Hernández, Gregory Y.H. Lip   +9 more
openalex   +1 more source

Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation [PDF]

, 2014
Tereza Lanitis, Thitima Kongnakorn, Lena Jacobson, Anna De Geer   +3 more
openalex   +1 more source

Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation [PDF]

, 2014
Sumesh Kachroo, Hemant Phatak, Paul Dorian, Thitima Kongnakorn, Tereza Lanitis, Andreas Kuznik, Jack Mardekian, X. Liu, John H. Lawrence, Gregory Y.H. Lip   +9 more
openalex   +1 more source

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation

, 2013
Greg Flaker, Renato D. Lópes, Sana M. Al‐Khatib, Antonio G. Hermosillo, Stefan H. Hohnloser, Brian Tinga, Jun Zhu, Puneet Mohan, David García, Jozef Bartúnek, Dragoş Vinereanu, Steen Husted, V.‐P. Harjola, Mårten Rosenqvist, John H. Alexander, Christopher B. Granger   +15 more
openalex   +1 more source

Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials [PDF]

, 2014
Stavros K. Kakkos, George Kirkilesis, Ioannis A. Tsolakis   +2 more
openalex   +1 more source

Spontaneous Pleural, Pericardial, and Intracranial Hemorrhages in a Patient with End-Stage Kidney Disease Receiving Apixaban: A Case Report. [PDF]

Am J Case Rep
Adetiloye AO, Ismail M, Alladin FK, Badero OJ.   +3 more
europepmc   +1 more source